Clustering of intuitive eating and psychological health identifies subgroups [PMID: 40177856] Laboratory literature summary: Clustering of intuitive eating and psychological health identifies subgroups associated with body-composition research following semaglutide
If you and your doctor find that none of them work for you without causing severe or long-lasting diarrhea, you may decide together to stop treatment and try another type of weight management medication
Eleven brands across six molecules, made almost entirely by two companies Novo Nordisk and Eli Lilly: Semaglutide (Novo Nordisk) Ozempic, Wegovy, Rybelsus Tirzepatide (Eli Lilly) Mounjaro, Zepbound Liraglutide (Novo Nordisk) Victoza, Saxenda Dulaglutide (Eli Lilly) Trulicity Exenatide (AstraZeneca) Byetta, Bydureon BCise Lixisenatide (Sanofi) Adlyxin, no longer marketed in the US For weight management , the FDA has approved Wegovy, Zepbound and Saxenda
Prescription products require an online consultation with a healthcare provider, who will determine if an individual is eligible for a prescription if medically appropriate in their independent clinical judgement
Common examples include side effects, insurance coverage changes, and availability issues
Insulin-like peptide 5 is an orexigenic gastrointestinal hormone
